<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01100918</url>
  </required_header>
  <id_info>
    <org_study_id>004844BLT</org_study_id>
    <nct_id>NCT01100918</nct_id>
  </id_info>
  <brief_title>Utility of Tissue Doppler Echocardiography for Selecting Patients for Cardiac Resynchronisation Therapy</brief_title>
  <acronym>TIBI-HF</acronym>
  <official_title>Utility of Tissue Doppler Echocardiography for Selecting Patients for Cardiac Resynchronisation Therapy in Heart Failure</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Barts &amp; The London NHS Trust</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Barts &amp; The London NHS Trust</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Currently the main selection tool for Cardiac Resynchronisation Therapy (CRT) is the QRS
      duration on the surface echocardiography (ECG) which has been shown to be a poor predictor of
      response. We sought to evaluate the use of tissue Doppler (TDI) assessment of dyssynchrony in
      prediction of response to CRT.

      The hypothesis is that the presence of mechanical dyssynchrony (measured using TDI
      echocardiography) successfully identifies heart failure patients who will respond to CRT.
      Conversely, the absence of mechanical dyssynchrony is associated with a low/no response to
      CRT.

      This is a three arm study. Group 1 comprises patients with dyssynchrony on TDI who are
      implanted with a biventricular ICD whereas Group 2 patients comprise patients who have no
      dyssynchrony. Group 2 patients are randomised 1:1 to either receive a biventricular ICD (2a)
      or an ICD (2b). All patients undergo a NYHA class assessment, a cardiopulmonary exercise
      test, and an echocardiogram at baseline and at 6 months follow up. Baseline and 6 months
      findings will be compared in all three groups.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>February 2007</start_date>
  <completion_date type="Actual">December 2010</completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Cardiopulmonary Exercise Testing - changes in Peak VO2 from baseline to 6 months</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in New York Heart Association (NYHA) class from baseline to 6 months</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Quality-of-Life score from baseline to 6 months</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Echocardiography - changes in left ventricular (LV) volume and dimensions, calculated ejection fractions and in severity of MR</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">80</enrollment>
  <condition>Heart Failure</condition>
  <arm_group>
    <arm_group_label>1: Dyssynchrony positive</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>2a: Dyssynchrony negative</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>2b: Dyssynchrony negative</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>BiV ICD</intervention_name>
    <description>Biventricular ICD</description>
    <arm_group_label>1: Dyssynchrony positive</arm_group_label>
    <arm_group_label>2a: Dyssynchrony negative</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>ICD</intervention_name>
    <description>Implantable Defibrillator</description>
    <arm_group_label>2b: Dyssynchrony negative</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Patients must have an indication for ICD therapy

          2. Heart failure of any aetiology with evidence of left ventricular (LV) systolic
             dysfunction with LV ejection fraction &lt; 35% and LV cavity dilatation (end diastolic
             dimension &gt; 55 mm)

          3. NYHA Class III/IV symptoms of heart failure despite optimal medical therapy

          4. QRS duration â‰¥120ms

        Exclusion Criteria:

          1. Reversible cause of heart failure such as ongoing ischaemia amenable to
             revascularisation or treatable valvular disease

          2. Requirement for ventricular pacing due to atrioventricular block.

          3. Limited life expectancy (&lt; 6 months)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Richard Schilling, MD, FRCP</last_name>
    <role>Principal Investigator</role>
    <affiliation>Barts and the London NHS Trust, Queen Mary University of London</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Barts and the London NHS Trust</name>
      <address>
        <city>London</city>
        <zip>EC1A 7BE</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>August 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 8, 2010</study_first_submitted>
  <study_first_submitted_qc>April 8, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 9, 2010</study_first_posted>
  <last_update_submitted>August 12, 2014</last_update_submitted>
  <last_update_submitted_qc>August 12, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 13, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Cardiac resynchronisation therapy</keyword>
  <keyword>Tissue Doppler Imaging</keyword>
  <keyword>Dyssynchrony</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

